Life Sciences MoForum 2023

Join Morrison Foerster as we explore the critical business, legal, and regulatory developments transforming the life sciences ecosystem at our annual Life Sciences MoForum in Boston. You will hear from leading investors, innovators, and strategists from across the life sciences industry, who will share their unique real-world insights on the challenges and opportunities that are driving innovation and growth in the sector today. 

With some uncertainty heading into 2023, our program will focus on the issues and trends that are impacting life sciences companies and offer practical strategies to navigate an evolving legal and regulatory landscape. Led by the MoFo Life Sciences team, our panels will feature industry and government leaders as they discuss developments in collaborations and licensing, enforcement and compliance, and life sciences investments. We will also feature some of the leading startups in the area during our emerging company showcase.

Our keynote speaker Harry Glorikian, General Partner at Scientia Ventures and influential global business expert, will join us for a luncheon to discuss the ongoing data-driven transformation of the life sciences industry and his latest book, “The Future You: How Artificial Intelligence Can Help You Get Healthier, Stress Less, and Live Longer.”

Our growing list of speakers also includes leaders from Sarepta Therapeutics, Cellens, BeiGene, CSPC Pharmaceutical Group, Polaris Partners, Sanofi Ventures, and more to be announced

This program is intended for life sciences and healthcare investors, entrepreneurs, executives, and corporate/general counsel.

Agenda

Thursday, January 26, 2023

8:30 a.m. – 9:00 a.m. | Registration + Breakfast

9:00 a.m. – 9:05 a.m. | Welcome Remarks with Michael Ward, Chair, Life Sciences + Healthcare Group, Morrison Foerster

9:05 a.m. – 9:55 a.m. | Life Sciences Enforcement and Compliance Outlook – Panel will discuss current life sciences enforcement and compliance issues in 2023 as well predictions for the next year, related to False Claims Act and Anti-Kickback Statute, clinical trial fraud, FDA enforcement, and implementation of recently revised DOJ corporate enforcement policies.

Moderated by: Nate Mendell, Partner, Morrison Foerster, former Acting U.S. Attorney for the U.S. Attorney’s Office for the District of Massachusetts

Panelists include:

• Stacy Cline Amin, Partner, Morrison Foerster, former FDA Chief Counsel and Deputy General Counsel of the Department of Health and Human Services
• Chad McDaniel, Senior Director, Regulatory and Employment Counsel, Sarepta Therapeutics

9:55 a.m. – 10:10 a.m. | Emerging Company Showcase featuring Click Therapeutics – Click Therapeutics develops and commercializes software as prescription medical treatments for patients with unmet medical needs.

• Shaheen Lakhan, Chief Medical Officer, Click Therapeutics, Inc.

• Laura Taraboanta, Senior Manager, Head of Clinical Innovations, Click Therapeutics, Inc.

10:10 a.m. – 11:00 a.m. | Collaborations + Licensing: Dealmaking Insights in the Life Sciences – This panel will explore trends in pharmaceutical and biotechnology dealmaking as well as recent case studies in life sciences licensing and collaborations. We will offer perspectives from both the licensor and licensee, and industry leaders will share insights on strategic considerations for these agreements.

Moderated by: Matt Karlyn, Partner, Morrison Foerster

Panelists include:

• Lauren Abel, Senior Transactions Counsel, Partnering and M&A, BeiGene
• John Adamou, Chief Business Officer, CSPC Pharmaceutical Group, Ltd.

• Jon Galli, Deputy General Counsel, Charles River Laboratories

11:00 a.m. – 11:15 a.m. | Emerging Company Showcase and Networking Break featuring Cellens – Cellens is a Tufts University spinout startup that is committed to bringing clarity and confidence to patients and physicians through noninvasive cancer detection. They are developing a pipeline of revolutionary noninvasive and accurate at-home and mail-in cancer monitoring tests.

• Jean Pham, Co-founder and CEO, Cellens

11:15 a.m. – 12:00 p.m. | Life Sciences Investments: What’s Trending Today – On the heels of the J.P. Morgan Healthcare Conference, our panelists will share insights on what 2023 may have in store for investing in the life sciences industry, the technologies and verticals investors are targeting, and the challenges that lie ahead in an uncertain economy.

Moderated by: Jim Krenn, Partner, Morrison Foerster

Panelists include:

• Alexandra Cantley, Partner, Polaris Partners
• Jason Hafler, Managing Director, Sanofi Ventures
• James Schneider, Deputy General Counsel, RA Capital Management, L.P.

12:00 p.m. – 1:00 p.m. | Networking Lunch + Keynote with Harry Glorikian – Harry Glorikian, General Partner at Scientia Ventures and influential global business expert, will join us for a keynote luncheon to discuss the ongoing data-driven transformation of the life sciences industry and his latest book, “The Future You: How Artificial Intelligence Can Help You Get Healthier, Stress Less, and Live Longer.”

Please note that Morrison Foerster’s event policy requires all attendees to be up-to-date on vaccinations for COVID-19.